L1 Global Manager’s CalciMedica CALC Stock Holding History

L1 Global Manager’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Buy	+248,972	New	+$176K	0.18%	93

Other funds holding CALC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

L1 Global Manager's CALC Position: Q2 2026 in Review

L1 Global Manager opened a new position in CalciMedica (CALC) in Q2 2026: 248,972 shares worth $256K. The stake represents 0.18% of the portfolio and ranks #93 among its holdings.

19 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

L1 Global Manager held 248,972 shares of CalciMedica worth $256K as of Q2 2026.
CalciMedica was a new L1 Global Manager position in Q2 2026.
CalciMedica made up 0.18% of L1 Global Manager's portfolio in Q2 2026, its #93 holding.
19 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on L1 Global Manager's 13F filing for Q2 2026, filed 13 Aug 2026.